Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
RESEARCH TOOLSreports
West Pharmaceutical Services (WST) Ownership Overview
0.56% Insiders
30.21% Mutual Funds
22.90% Other Institutional Investors
26.59% ETFs
19.75% Public Companies and Individual Investors
The ownership structure of West Pharmaceutical Services (WST) stock is a mix of institutional, retail, and individual investors. Approximately 79.70% of the company’s stock is owned by Institutional Investors, 0.56% is owned by Insiders, and 19.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 31, 2024 | Charles Witherspoon Vp & Treasurer | xxxxxxxxxxxxx | $218211 |
| Aug 21, 2024 | Charles Witherspoon Vp & Treasurer | xxxxxxxxxxxxx | $308700 |
| Aug 21, 2024 | Thomas Hofmann Director | xxxxxxxxxxxxx | $225773 |
| Jun 13, 2024 | Abraham Silji Svp & Cto | xxxxxxxxxxxxx | $595404 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $5896080 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $9414729 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,278,783 | Institution | 11.43% | 1,777,703,074 | |
| 7,202,757 | Institution | 9.95% | 1,546,648,011 | |
| 3,998,934 | Institution | 5.52% | 858,691,098 | |
| 2,704,722 | Institution | 3.73% | 580,784,955 | |
| 1,322,781 | Institution | 1.83% | 284,040,764 | |
| 1,181,625 | Institution | 1.63% | 253,730,336 | |
| 839,141 | Institution | 1.16% | 180,188,747 | |
| 809,366 | Institution | 1.12% | 173,795,161 | |
| 767,305 | Institution | 1.06% | 164,763,403 | |
| 751,424 | Institution | 1.04% | 161,353,276 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,202,757 | Institution | 9.95% | 1,546,648,011 | |
| 1,322,781 | Institution | 1.83% | 284,040,764 | |
| 1,181,625 | Institution | 1.63% | 253,730,336 | |
| 809,366 | Institution | 1.12% | 173,795,161 | |
| 767,305 | Institution | 1.06% | 164,763,403 | |
| 751,424 | Institution | 1.04% | 161,353,276 | |
| 700,357 | Institution | 0.97% | 150,387,659 | |
| 657,366 | Institution | 0.91% | 141,156,201 | |
| 502,284 | Institution | 0.69% | 107,855,443 | |
| 433,000 | Institution | 0.60% | 92,978,090 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,275,176 | Institution | 3.14% | 745,256,651 | |
| 1,961,648 | Institution | 2.71% | 642,557,419 | |
| 1,557,252 | Institution | 2.15% | 510,093,465 | |
| 887,761 | Institution | 1.23% | 176,762,093 | |
| 887,761 | Institution | 1.23% | 176,762,093 | |
| 849,736 | Institution | 1.17% | 182,463,811 | |
| 805,222 | Institution | 1.11% | 263,758,518 | |
| 611,769 | Institution | 0.84% | 121,809,326 | |
| 536,597 | Institution | 0.74% | 175,767,713 | |
| 514,211 | Institution | 0.71% | 102,384,552 |
FAQ
Who Owns West Pharmaceutical Services, Inc. (WST)?
According to the latest TipRanks data, approximately 22.90% of the company's stock is held by institutional investors, 0.56% is held by insiders, and 19.75% is held by retail investors.
What percentage of West Pharmaceutical Services, Inc. (WST) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.90% of West Pharmaceutical Services, Inc. (WST) stock is held by institutional investors.
What percentage of West Pharmaceutical Services, Inc. (WST) stock is held by retail investors?
According to the latest TipRanks data, approximately 19.75% of West Pharmaceutical Services, Inc. (WST) stock is held by retail investors.
Who owns the most shares of West Pharmaceutical Services, Inc. (WST)?
Vanguard owns the most shares of West Pharmaceutical Services, Inc. (WST).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.